Pulmonology Prior Auth: How AI Handles Respiratory Medication Approvals

A pulmonology patient with severe asthma needs to start a biologic therapy. The medication costs $15,000-$30,000 annually. The insurer wants documentation of IgE levels, eosinophil counts, failed step-therapy with two previous controller medications, and the prescribing physician’s clinical rationale. The prior auth timeline is 7-14 business days.

Your billing specialist submits the request. The patient calls twice a week to ask if it’s approved. The insurance company loses the fax once. You resubmit. Two weeks later, the approval lands. The patient has been symptomatic for a month waiting.

This is pulmonology prior authorization at its worst. And it’s not the exception - it’s the standard experience for practices prescribing biologics, specialty inhalers, and home respiratory equipment for their sickest patients.

Pulmonology practices carry a prior authorization burden that comes from two directions: the high cost of respiratory biologics that require extensive step-therapy documentation, and the steady volume of authorization requests for inhalers, sleep apnea equipment, and pulmonary function testing that are routine in volume but still require staff time. AI voice agents are handling the inbound patient communication layer around prior authorization - status calls, documentation requests, appeal follow-up routing - so staff can focus on the submissions themselves.

The prior auth picture in pulmonology

Pulmonology’s prior authorization requirements come from three distinct categories:

Biologic therapies for severe asthma

The biologic class for severe asthma (dupilumab, mepolizumab, omalizumab, benralizumab) represents some of the most documentation-intensive prior authorization in outpatient medicine. Payers require:

• Biomarker documentation (IgE, eosinophil counts, FeNO where applicable)
• Step-therapy failure documentation (typically 2+ controller medications at maximum tolerated dose)
• Asthma control questionnaire or spirometry results
• Emergency department visits or hospitalization history
• The specific biologic and dosing regimen with clinical rationale

A single biologic prior auth can take 2-4 hours of staff time to compile and submit. Denials and appeals add another 2-3 hours per case. For a pulmonology practice prescribing 10-15 biologics per year, that’s 40-80 staff hours annually on biologic prior auth alone.

Inhaler prior authorization and step therapy

Commercial payers impose step therapy requirements on specialty inhalers. A patient who needs a specific LAMA/LABA combination may first need documentation of failure with cheaper alternatives - even if the prescribing physician has clinical reasons to start with the preferred agent.

ICS/LABA combinations, LAMA agents, and rescue inhalers with preferred-brand tiers all generate prior auth requests that, individually, take 20-30 minutes each. For a practice with 300+ active COPD and asthma patients, inhaler prior auth is a persistent background workload.

CPAP and home respiratory equipment

When pulmonologists diagnose and manage obstructive sleep apnea, the prescription for CPAP equipment requires prior authorization based on sleep study documentation. Home oxygen therapy and home nebulizer equipment have their own documentation requirements. Payers often require reauthorization at 90-day intervals for ongoing home equipment coverage.

The patient call problem in pulmonology

Pulmonology patients - particularly those with COPD, severe asthma, and pulmonary fibrosis - call their practices frequently. The conditions are chronic, fluctuating, and anxiety-generating. Patients want to know whether their medication is approved, whether the exacerbation they’re experiencing warrants an ER visit, and how to manage symptom changes between office visits.

Prior auth status calls are the highest volume administrative inquiry. A patient prescribed a biologic calls every few days to ask if it’s been approved. AI checks athenahealth for current authorization status and gives a direct answer. If it’s pending an appeal, the AI provides the status and offers a billing callback.

Symptom triage calls require a more careful AI protocol. COPD and asthma patients calling with acute symptom changes need to be triaged by severity - increasing dyspnea and reduced peak flow are different from mild symptom variation. AI handles the initial triage intake, collecting symptom information according to a clinical protocol, and routes urgent calls to the on-call provider while handling routine status calls without clinical staff involvement.

CPAP and equipment questions are largely protocol-driveable. Patients calling with CPAP mask fit issues, humidity settings, or pressure adjustment questions can be routed to the respiratory therapist or equipment vendor through an AI triage flow.

Where AI fits in the pulmonology prior auth workflow

AI doesn’t write the biologic prior auth submissions. That requires clinical judgment and knowledge of payer-specific requirements that is legitimate specialist work.

AI handles the surrounding communication:

Inbound patient status calls When a patient calls asking whether their dupilumab prescription is approved, that answer is in athenahealth. The AI checks the auth record and gives the patient a status update. For pending cases, it offers a timeline estimate and a billing callback for complex situations. Staff handling the actual submissions aren’t interrupted by every status inquiry.

Documentation request routing When a payer requests additional documentation to support a prior auth - more common in respiratory biologics than in most specialties - that request needs to reach the right clinical staff quickly. AI handles the inbound notification, logs it in athenahealth with an urgency flag based on patient appointment proximity, and queues it for clinical staff action.

Reauthorization expiration alerts CPAP equipment reauthorizations, home oxygen reauthorizations, and some biologic reauthorizations require renewal on a schedule. AI tracks authorization expiration dates in athenahealth and triggers outbound staff alerts when renewals fall due, preventing the gap where a patient’s equipment authorization lapses and coverage interrupts.

Post-denial patient notification When a prior auth is denied, the patient needs to be notified and the appeals process needs to be explained. AI handles the initial outbound notification call, provides factual information about the denial and the next steps, and routes patients with questions about the appeal to billing.

The COPD patient population

COPD patients represent a high-contact population in pulmonology. They have exacerbations, medication side effects, and anxiety about their disease trajectory. They are often older, may have limited comfort with patient portals, and prefer phone contact.

The call patterns from COPD patients:

• Exacerbation calls (“I’m more short of breath than usual”)
• Medication refill requests (particularly for rescue inhalers and oral corticosteroids)
• Prior auth status for inhalers and biologics
• Questions about activity and diet during exacerbation
• Follow-up scheduling after hospitalizations

AI handles the administrative and triage layers of these calls, separating the calls that need clinical response from the calls that need billing response or scheduling response - without requiring front desk staff to make that judgment for every inbound call during peak hours.

What pulmonology practices get from AI

For a 3-physician pulmonology practice with 300+ active COPD and asthma patients:

Prior auth status call deflection: The single highest-volume administrative inquiry in pulmonology - “is my medication approved?” - handled through AI lookup without staff interruption.

Biologic prior auth workflow support: Documentation request routing and patient notification around biologic prior auth reduces the communication overhead that surrounds each high-stakes submission.

COPD symptom triage support: An initial triage layer that separates urgent symptom calls from routine administrative calls, so clinical staff focus on the calls that need them.

CPAP and equipment call routing: Home respiratory equipment questions route appropriately without front desk triage on every call.

Key takeaways

• Pulmonology prior auth comes from three distinct tracks: respiratory biologics (high documentation burden), inhaler step therapy (high volume), and home respiratory equipment (recurring reauthorizations)
• COPD and asthma patients call frequently for prior auth status updates - AI handles the lookup and status delivery without staff interruption
• Documentation request routing for biologic denials needs to happen quickly - AI triage with urgency flags based on appointment proximity reduces the risk of missed deadlines
• CPAP reauthorization expirations are preventable with proactive tracking and alerts - AI manages this in athenahealth before gaps occur
• A 3-physician pulmonology practice managing 300+ chronic respiratory patients needs a call triage system that separates urgent symptom calls from administrative calls consistently

If your billing staff is handling both biologic prior auth submissions and the daily patient status calls around those submissions, you’re pulling the same people in two directions simultaneously.

See how Pretty Good AI handles pulmonology practice workflows in athenahealth

Sources:

• American Medical Association 2024 Prior Authorization Survey: Prior Authorization Reform
• American Thoracic Society, Prior Authorization in Respiratory Medicine: ATS Resources